PART I: THE SECOND BEGINNING
This section introduces chlorine dioxide (ClO₂) as a low-cost, unpatentable compound with broad-spectrum antimicrobial properties and potential therapeutic applications against a variety of diseases including cancer, AIDS, malaria, and COVID-19. Dr. Pierre Kory, a pulmonary and critical care specialist, frames chlorine dioxide as a molecule with a long history of safe industrial and external use but facing intense suppression by pharmaceutical companies, regulatory agencies, and governments when proposed for internal therapeutic use. The author emphasizes the need for open scientific inquiry and regulatory approval while cautioning about dosing and refraining from recommending specific protocols.
The narrative highlights the personal persecution of chlorine dioxide advocates and pioneers, underscoring the political and economic interests that have led to widespread censorship and disinformation campaigns. The metaphor of chlorine dioxide as a purifier that removes harmful elements while preserving beneficial ones symbolizes a call for a new mindset in medicine beyond profit-driven motives.
PART II: THE HISTORY
This part traces the historical development, scientific background, and sociopolitical context surrounding chlorine dioxide and related oxidative therapies.
Chapter 1: The Kory Scale
The "Kory Scale" is introduced as a conceptual tool correlating the degree of institutional persecution of a therapy with its probable efficacy and threat to pharmaceutical interests. Therapies scoring high on this scale, such as ivermectin and chlorine dioxide, are characterized as safe, effective, inexpensive, and broadly applicable but suppressed due to economic threats. The scale contrasts with the Semmelweis Reflex by focusing on economic and political suppression rather than mere resistance to new ideas. The chapter documents persecution including smear campaigns, arrests, and assassination attempts against proponents.
Chapter 2: A Disclaimer of Sorts
The book’s scientific analysis of chlorine dioxide is placed toward the end to maintain reader engagement. Key scientific facts are summarized upfront: chlorine dioxide selectively destroys pathogens rapidly without toxic byproducts, is safe for regulated oral and topical use, inhibits cancer cell growth, supports immune balance, and has growing published evidence despite regulatory resistance.
Chapters 3 & 4: The (Untold) History, Parts I & II
These chapters provide a detailed historical account of chlorine dioxide’s discovery, industrial adoption, and therapeutic potential. From its accidental discovery in 1811 to widespread use in water purification and medical sterilization, chlorine dioxide has a long-standing safety record. Nikola Tesla’s early work on ozone and oxidative therapies is noted as foundational.
Jim Humble’s 1996 discovery of chlorine dioxide’s therapeutic potential for malaria is highlighted, alongside regulatory warnings such as the FDA’s 2010 caution against Miracle Mineral Solution (MMS). Despite demonization for internal use, chlorine dioxide continues to be used safely in industrial and emergency contexts (e.g., FEMA’s use post-anthrax attacks and Hurricane Katrina).
An anonymous retired applied scientist known as "Colonel Mondragon" (CM) provides insider testimony about chlorine dioxide’s use in chemical and biological warfare countermeasures, water treatment in Nigeria, and its unexpected malaria-curing effects confirmed by local doctors. The chapter recounts how powerful interests, including a Ghanaian epidemiologist-king, suppressed widespread distribution due to concerns about population growth and famine, illustrating the complex interplay of health, politics, and economics.
Chapter 5: The Plot Thickens
This chapter explores the persecution of pioneers in oxidative therapies such as Dr. William F. Koch and Dr. F.M. Eugene "Fritz" Blass, who developed Homozon, an oral oxidative therapy possibly in collaboration with Nikola Tesla. Blass’s work and existence have been heavily erased, and he was allegedly murdered to suppress his discoveries. The chapter also discusses Dr. George Freibott, a Tesla protégé and oxidative medicine advocate, and Ed McCabe, an oxygen therapy promoter. The systematic suppression of oxidative therapies and their pioneers is emphasized.
Chapter 6: A Weird Detour Through Bolivia
Bolivia’s legalization of oral chlorine dioxide for COVID-19 treatment in 2020, despite opposition from global health agencies, is detailed. The military and universities distributed chlorine dioxide under strict protocols, with millions treated and dramatic improvements in COVID-19 outcomes reported. However, international bodies and media strongly opposed and discredited chlorine dioxide. Similar legislative efforts in Brazil and Peru faced political suppression after regime changes.
Chapter 7: My Personal Experience
The author documents the phenomenon of post-COVID hospital phobia, citing studies showing reduced hospitalization and mortality with home treatments including povidone-iodine. Public trust in physicians and hospitals declined sharply due to the medical system’s COVID response. The author critiques evidence-based medicine as manipulated by pharmaceutical interests favoring expensive patented drugs over cheap repurposed therapies like ivermectin.
Personal anecdotes include the author’s successful home treatment of severe abdominal illness with chlorine dioxide, vitamin C, and IV fluids, avoiding hospitalization. Speculation about intentional poisoning and chlorine dioxide’s detoxifying properties is presented cautiously. The author stresses that self-treatment is not recommended without medical supervision.
PART III: THE PIONEERS AND PERSECUTIONS
This part profiles key individuals who pioneered chlorine dioxide therapies and documents the persecution they faced.
Chapter 8: Howard Alliger
Howard Alliger, a scientist and inventor in the 1970s, discovered chlorine dioxide’s therapeutic potential while developing sterilizers for ultrasonic cleaning tanks. He applied chlorine dioxide topically to skin conditions with positive results and developed around 20 chlorine dioxide products for various uses including wound healing and fungal infections. His company Alcide produced these products but faced challenges gaining acceptance from pharmaceutical companies despite FDA cooperation.
Alliger distinguished chlorine dioxide from chlorine, emphasizing its lack of carcinogenic byproducts. Despite demonstrated benefits, pharmaceutical industry reluctance limited adoption. The chapter notes the difference between chlorine dioxide solution (CDS) and Jim Humble’s Miracle Mineral Supplement (MMS) in preparation and use.
Jim Humble, an electronics technician and self-taught researcher, promoted ingestion of chlorine dioxide as Miracle Mineral Supplement (MMS). His discovery originated in 1996 during a gold mining expedition in Guyana where suspected malaria patients recovered rapidly after treatment with sodium chlorite water purifier drops. Humble developed MMS1, mixing sodium chlorite with acid to produce chlorine dioxide solution, and trained thousands to treat diseases including malaria, typhoid, dengue, and HIV.
Despite intense opposition from regulatory agencies and media labeling MMS as industrial bleach, Humble maintained that MMS supports the body’s self-healing rather than directly curing diseases. He co-founded the Genesis II Church of Health and Healing to promote MMS as a sacrament, circumventing medical restrictions. Humble and associates faced persecution including forced expulsion, violent attacks, and raids. He died at age 91, leaving a legacy of anecdotal recoveries.
Mark Grenon, co-founder of Genesis II Church with Humble, is a leading clinician using chlorine dioxide in various forms. With a background as a medical missionary pilot and surgical assistant, Grenon successfully treated his family’s MRSA infections with MMS. He expanded MMS use globally, treating diseases such as elephantiasis, dengue, AIDS, cancer, and diabetes.
The Genesis II Church grew to 115 countries with 1,800 trained health ministers, framing MMS as a religious sacrament to avoid legal restrictions. Grenon survived alleged assassination attempts and faced escalating persecution including raids, arrests, and confiscations by multiple U.S. agencies. He and family members served prison sentences on conspiracy charges, with ongoing legal challenges highlighting violations of religious freedom and due process.
Despite persecution, Grenon and the church continue to advocate for accessible chlorine dioxide therapy worldwide.
Chapter 11: Enno Freye
Enno Freye, a German anesthesiologist and professor, researched sublingual chlorine dioxide tablets for malaria treatment. His 2018 study in Cameroon showed rapid symptom reversal but was retracted amid accusations of fabrication. Freye lost academic titles and was imprisoned after being framed for drug trafficking during a UN funding trip. He alleges suppression by pharmaceutical interests protecting vaccine agendas.
Freye’s sublingual formulation bypasses gastrointestinal side effects, delivering chlorine dioxide gas directly into the bloodstream. Swiss regulatory authorities banned his products citing health risks. He continues research on Long COVID and vaccine injury treatments, emphasizing the need for alternative medicine free from pharmaceutical influence.
Chapter 12: The Curious Outlier
An anonymous nurse known as “Jeff,” with pediatric critical care and military experience, became a chlorine dioxide advocate after personal research starting in 2015. Initially fearful due to FDA warnings, he embraced chlorine dioxide after extensive study and testimonies. Jeff produced a documentary titled "The Universal Antidote" and created educational resources and training courses in multiple languages. He maintains anonymity due to professional risks but actively promotes chlorine dioxide through online platforms.
PART IV: NOTABLE MODERN-DAY PROPONENTS
This part profiles contemporary advocates who have contributed to chlorine dioxide awareness and applications.
Chapter 13: Michelle Herman
Michelle Herman entered the chlorine dioxide field in 2009, partnering with Howard Alliger to develop a nasal spray for sinus infections branded as Snoot!. The product uses DioxiCare technology, a cinnamon-scented chlorine dioxide superfine mist stable for a week. Marketed as a cosmetic to avoid regulatory issues, it carries no FDA approval or medical claims.
Herman believes chlorine dioxide neutralizes bioweapons and treats diverse conditions including Lyme disease, anthrax, HIV, COVID-19, autism, and vaccine injury by breaking down toxins and supporting oxygen delivery. She advocates for wider awareness of chlorine dioxide’s broad-spectrum efficacy and safety.
Chapter 14: David Oates
David Oates, a former U.S. Air Force jet-engine mechanic, became a chlorine dioxide advocate after personal and family experiences during COVID-19. He began chlorine dioxide use in April 2020, successfully treating his mother’s severe illness and publicly documenting her recovery. Oates founded online communities for sharing chlorine dioxide testimonies and support, hosting regular audio chats.
He lost social media presence and professional real estate license due to activism. Oates emphasizes challenges in dosing moderation and the importance of community support and evidence-based sharing. He sees his role as a connector and encourager within the chlorine dioxide movement.
Chapter 15: Kerri Rivera
Kerri Rivera, a Doctor of Homeopathy, began exploring chlorine dioxide after her son Patrick was diagnosed with autism. After unsuccessful conventional and alternative therapies, she revisited chlorine dioxide-based "detoxification drops." Despite initial adverse reactions, her son showed rapid and significant improvements including regained eye contact and smiling.
Rivera attributes chlorine dioxide’s effects to its ability to open viral envelopes, kill pathogens, neutralize heavy metals, reduce inflammation, and support detoxification. She advocates chlorine dioxide as a powerful tool against autism and vaccine injury, emphasizing affordability and accessibility.
Rivera faced intense backlash including legal investigations and social media bans, but all charges were eventually dropped. She remains a central figure in an international parent support network advocating chlorine dioxide for autism.
Chapter 16: Susan Raj
Dr. Susan Raj, with over 30 years in healthcare including nursing during the HIV/AIDS crisis and social work, developed “integrative cellular detox therapy” combining chlorine dioxide (called “di-oxygen chloride”) with DMSO, diet, fasting, and stress reduction. Her early work with HIV patients in India showed zero mortality in a year using SAM therapy (selenium, aspirin, multivitamins) and dietary changes.
After self-treating severe food poisoning successfully with chlorine dioxide, Raj treated patients with remarkable results including liver damage reversal and herpes relief. She operates carefully within India’s integrative medicine framework due to regulatory constraints and emphasizes detoxification as the core remedy for disease.
Andreas Kalcker, a German biophysical researcher, is a prominent advocate of chlorine dioxide solution (CDS) for diseases including cancer and degenerative conditions. He has authored books and founded a CDS research institute in Mexico, maintaining a website compiling scientific papers and testimonials.
Kalcker’s advocacy is controversial; in 2021 Argentine authorities charged him with falsely promoting a toxic substance after a child’s death linked to chlorine dioxide use during COVID-19. The case is ongoing. Despite legal challenges and media attacks, Kalcker remains a vocal proponent of chlorine dioxide therapy.
PART V: THE MEDIA HIT JOBS
This part documents media and institutional efforts to discredit chlorine dioxide therapies and their proponents.
Chapter 18: The Red Cross Malaria Trial
A 2012 clinical trial in Uganda tested therapeutic doses of MMS (chlorine dioxide precursor) against malaria in 154 patients, resulting in all patients being malaria-free within 48 hours without side effects. The trial was documented by filmmaker Mustaque Abdallah, featuring interviews with Red Cross officials and local authorities.
Despite documented success, the Red Cross and IFRC denied involvement, claiming no trial took place and alleging staff were “duped.” The documentary was removed from YouTube after media pressure but remains on alternative platforms. Evidence includes project plans, audiovisual documentation, and testimonies.
Media outlets dismissed the trial as fake, promoting regulatory narratives labeling MMS as toxic bleach. The author argues this suppression exemplifies coordinated censorship causing preventable deaths.
Chapters 19 & 20: TrialSiteNews Controversy
TrialSiteNews (TSN), a media outlet, published critical articles attacking the author’s pro-chlorine dioxide position, accusing reliance on anecdotal evidence and lacking randomized clinical trials. The author rebuts these claims, citing 39 peer-reviewed studies, multiple RCTs, and documented suppression of research.
The author exposes TSN’s pharmaceutical industry ties and regulatory bias, highlighting inconsistencies between FDA warnings and EPA/WHO safety data. TSN’s critiques are characterized as censorship masquerading as journalism. Public support for the author’s position grew following TSN’s doubling down.
Chapter 21: The Universal Curse
Mainstream media uniformly malign chlorine dioxide, labeling it toxic bleach and pseudoscience. Activists like Fiona O’Leary lead coordinated campaigns against chlorine dioxide advocates. Media focus on worst-case scenarios ignores clinical data and silences families seeking alternatives. This framing suppresses research and healthy debate.
PART VI: THE SCIENCE AND SAFETY
This part presents the chemical, pharmacological, clinical, and safety data supporting chlorine dioxide’s therapeutic potential.
Chapter 22: The Science
Chlorine dioxide differs chemically and functionally from bleach (sodium hypochlorite), acting as a selective oxidizer with fewer harmful byproducts. It is effective across a wide pH range, stable in small doses, and used safely in water treatment and medical contexts.
CD targets pathogens precisely without damaging healthy tissue and modulates immune responses, potentially benefiting autoimmune diseases. Emerging evidence suggests CD may inhibit viral spike protein binding and exhibit anti-cancer activity in vitro and in vivo. Dosing requires careful titration and multiple small doses daily. Regulatory agencies universally prohibit oral CD use for disease treatment despite evidence of safety at low doses.
Chapter 23: The Clinical Studies
Numerous studies demonstrate CD’s broad antimicrobial activity against viruses (hepatitis, HPV, HIV, Ebola), bacteria, fungi, and parasites. Animal studies show reduced mortality in influenza-infected mice and effective treatment of mastitis in cows. Malaria studies in Uganda, Cameroon, and Nigeria show high recovery rates but faced suppression.
CD effectively treats herpes, candidiasis, halitosis, and improves oral hygiene. Sinusitis patients improved with nasal sprays. Case reports document success in treating oral ulcers, diabetic foot ulcers, Fournier’s gangrene, burns, and veterinary infections. A Japanese study showed reduced respiratory illness absenteeism in classrooms.
COVID-19 studies report high efficacy in prevention, treatment, and Long COVID symptom reduction, though many trials faced regulatory barriers. Tuberculosis treatment with CD is reported but unpublished. Limited clinical case series suggest CD may inhibit cancer cell growth and stimulate anti-cancer immune responses, with notable cases of metastatic pancreatic and breast cancer showing stabilization or improvement.
Chapter 24: The Safety
Chlorine dioxide is less toxic and more selective than chlorine bleach. Regulatory safety limits vary: EPA allows up to 0.8 ppm (approx. 2 mg/day) in drinking water; WHO suggests tolerable daily intake around 5 mg/day; emergency water treatment allows up to 10 mg/day short-term. Studies show even 24 mg/day orally and IV doses up to 224 mg/day chlorite in ALS patients were well tolerated.
LD50 estimates indicate low acute toxicity. Adverse effects in humans are rare and mostly mild (nausea, diarrhea). FDA Adverse Event Reporting System recorded only 5 MMS-related adverse events over 10 years with no confirmed deaths, contrasting with tens of thousands for common drugs like aspirin. Media and regulatory agencies often conflate chlorine dioxide with bleach, leading to misinformation.
Chlorine dioxide is widely consumed daily in treated water globally, including mass distribution in Bolivia during COVID-19 with positive outcomes. The author criticizes regulatory inconsistencies and calls for rational evaluation of safety data.
Chapter 25: The Protocols
Jim Humble’s original oral ingestion method involved sodium chlorite tablets or liquid activated by stomach acid to produce chlorine dioxide (MMS). MMS1 is a pre-activated sodium chlorite mixed with acid before ingestion, improving efficacy. Pharmacokinetic studies indicate chlorine dioxide rapidly reduces to chlorite in the stomach; systemic absorption is mainly chlorite.
MMS1 dosing involves mixing sodium chlorite and acid drops, reacting briefly, then diluting before ingestion, often every 45–60 minutes over 8–12 hours. Exact dosing is difficult to quantify due to variability; titration based on tolerance is recommended. Estimated maximum daily chlorine dioxide dose in Humble’s Protocol 1000 is ~148 mg, below no observed adverse effect level (NOAEL).
Chlorine Dioxide Solution (CDS) is fully activated chlorine dioxide gas dissolved in water, free of sodium chlorite and acid, offering more dose consistency and less taste/odor but more complex preparation. CDS lacks sodium chlorite, which may have additional therapeutic effects; MMS1 is preferred for oral use, CDS favored for IV, IM, or enema administration. Both are considered effective and safe when used properly. The field lacks advanced pharmacokinetic research due to regulatory and funding barriers; clinical observation and careful self-monitoring remain essential.
Chapter 26: The Testimonials
Thousands of personal testimonials worldwide report chlorine dioxide efficacy for infections, autoimmune diseases, cancer, and wound healing, often after conventional treatments failed. Testimonials are often anonymous due to stigma and regulatory backlash but show consistent symptom relief and recovery patterns. Clinicians’ anecdotal experiences corroborate some patient reports.
While lacking rigorous clinical trial design, these grassroots data highlight unmet medical needs and potential benefits. Public health agencies maintain strict opposition to chlorine dioxide as a treatment, emphasizing disinfectant use only. The persistence and volume of testimonials suggest a need for serious scientific evaluation rather than dismissal.
EPILOGUE: THE SILENCING OF SCIENCE
Despite accumulating evidence, scientific and regulatory institutions largely ignore or suppress chlorine dioxide research and clinical trials, especially oral administration studies in the U.S. The lack of profit motive and entrenched medical-industrial interests contribute to this suppression. The author criticizes media and regulatory narratives dismissing chlorine dioxide as conspiracy or bleach, ignoring scientific data and patient experiences.
The epilogue calls for lifting research restrictions to enable rigorous clinical trials and broader acceptance if efficacy and safety are confirmed. It highlights the conflict between public health messaging and emerging evidence, framing chlorine dioxide as a molecule suppressed due to economic and institutional inertia rather than scientific merit.
ACKNOWLEDGEMENTS
The author expresses gratitude to a network of chlorine dioxide researchers, scientists, and practitioners who contributed expertise and support. Key individuals include Dr. Mitch Liester (University of Colorado), The Curious Outlier (critical care nurse), Colonel Mondragon (anonymous scientist), Michelle Herman and Valerie Alliger (Frontier Pharmaceuticals), Raul Pineda Piñero, Tom Henshaw, Jose Nasser MD, PhD, Dr. Laurent Schwartz, and David Nelson.
Foundational sources include Jim Humble’s books, Andreas Kalcker’s website, Robert Yoho’s essays, and Frontier Pharmaceuticals’ scientific papers. Jenna McCarthy, co-writer, is credited for writing skill, humor, and organizational contributions including the Epilogue.
RESOURCES
The book provides a comprehensive list of websites, newsletters, documentaries, interviews, and organizations related to chlorine dioxide research and advocacy. Notable resources include Dr. Pierre Kory’s and Jenna McCarthy’s Substack newsletters, The Universal Antidote website and course, Frontier Pharmaceuticals, the Quantum Leap documentary, interviews with pioneers like Howard Alliger and Jim Humble, and scientific white papers.
ABOUT THE AUTHORS
Dr. Pierre Kory is a pulmonary and critical care specialist, educator, author, and advocate for evidence-based medicine. He co-founded the Front Line COVID-19 Critical Care Alliance (FLCCC) and The Leading Edge Clinic, and is active in telehealth and public health advocacy.
Jenna McCarthy is an experienced writer, speaker, and author with a background in humor and social commentary. She co-authored The War on Ivermectin and is an active commentator on medical freedom and government overreach.
REFERENCES
The book includes extensive citations covering scientific articles, government reports, clinical trials, documentaries, news articles, and advocacy materials. References encompass peer-reviewed studies on chlorine dioxide’s antimicrobial properties, safety profiles, and potential therapeutic applications, as well as reports on controversies, misinformation campaigns, and regulatory actions.
Several references address chlorine dioxide’s use in malaria, COVID-19, cancer, and other diseases, alongside critical analyses, interviews, and historical documentation of chlorine dioxide’s medical use and suppression.
Overall Scope and Usefulness
The War on Chlorine Dioxide offers a comprehensive, detailed exploration of chlorine dioxide’s history, science, clinical applications, and the extensive political and economic suppression it faces. The book is intended for researchers, clinicians, advocates, and informed readers interested in alternative therapies, medical freedom, and the intersection of medicine with regulatory and corporate interests.
It provides valuable historical context, profiles of key pioneers, summaries of scientific and clinical evidence, and documentation of media and institutional censorship. The book’s extensive references and resources support further investigation. While it does not provide formal treatment protocols, it emphasizes safety data, dosing considerations, and the need for open scientific inquiry.
The book’s critical perspective on mainstream medical orthodoxy and pharmaceutical influence, combined with detailed documentation of chlorine dioxide’s potential, makes it a significant resource for those researching low-cost, accessible antimicrobial and anticancer options, especially in contexts where conventional treatments are limited or inaccessible.
Cautions include the controversial nature of chlorine dioxide use, regulatory prohibitions on oral administration, and the need for medical supervision. The book reflects the author’s advocacy position and should be considered alongside broader scientific and regulatory literature.
